Positive and etiliological diagnosis of acute pancreatitis;Comment faire le diagnostic positif et étiologique de pancréatite aiguië?

Gastroenterologie Clinique et Biologique

Volumn 25, Issue 1 SUPPL., 2001, Pages

  Malka, David ^a   Rosa Hézode, Isabelle ^b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Acute pancreatitis; Diagnosis; Etiology

Indexed keywords

AMYLASE; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; BILIARY TRACT DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC IMAGING; ECHOGRAPHY; ENZYME BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS;

ACUTE DISEASE; BILE DUCT DISEASES; DIAGNOSTIC IMAGING; HUMANS; PANCREAS; PANCREATITIS;

EID: 0035097733     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (267)

1. A clinically based classification system for acute pancreatitis: Summary of the Atlanta symposium
2. Deaths from acute pancreatitis: Why do we miss the diagnosis so frequently?
3. Diagnosis of acute pancreatitis
4. Effects of pancreatitis on the small bowel and colon: Spread along mesenteric planes
5. Cullen's sign associated with metastatic thyroid cancer
6. Acute pancreatitis: A multisystem disease
7. Diabetic ketoacidosis, hyperlipidemia, and acute pancreatitis: The enigmatic triangle
8. Susceptibility of the pancreas to ischemic injury in shock
9. Postoperative pancreatitis: A study of seventy cases
10. United Kingdom guidelines for the management of acute pancreatitis
11. Lipase and pancreatic amylase activities in tissues and in patients with hyperamylasemia
12. Isoelectric focusing studies of human serum and tissue isoamylases
13. Diagnosis of acute pancreatitis: Any news or still amylase?
14. Serum elastase 1 in inflammatory pancreatic and gastrointestinal diseases and in renal insufficiency. A comparison with other serum pancreatic enzymes
15. Radioimmunoassay for human pancreatic lipase in acute pancreatitis
16. Acute pancreatitis and normoamylasemia. Not an uncommon combination
17. Diagnosis of acute pancreatitis: A proposed sequence of biochemical investigations
18. Serum amylase, isoamylase, and lipase in the acute abdomen. Their diagnostic value for acute pancreatitis
19. Diagnostic and prognostic utility of phospholipase A activity in patients with acute pancreatitis: Comparison with amylase and lipase
20. Serum pancreatic enzyme assays in acute abdomen: A comparative prospective study
21. Amylase, lipase, pancreatic isoamylase, and phospholipase A in diagnosis of acute pancreatitis
22. What is the best biochemical test to diagnose acute pancreatitis? A prospective clinical study
23. Evaluation of a new urinary amylase test strip in the diagnosis of acute pancreatitis
24. A comparison of lipase and amylase in the diagnosis of acute pancreatitis in patients with abdominal pain
25. Diagnostic assays in acute pancreatitis. A study of sensitivity and specificity
26. Sensibilité et spécificité de l'amylasémie. Du rapport des clairances d'amylase et de créatinine et du rapport amylasurie/créatininurie pour le diagnostic des pancréatites aiguës
27. The value of immunoreactive lipase in acute pancreatitis
28. The pancreatic enzymes value in the diagnosis of acute pancreatitis and acute biliary tract diseases
29. Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease
30. Enzyme immunoassay for serum pancreatic lipase in the diagnosis of pancreatic diseases
31. Serum lipase levels in nonpancreatic abdominal pain versus acute pancreatitis
32. Diagnosis accuracy evaluation using ROC curve analysis
33. Normal amylase levels in the presentation of acute pancreatitis
34. Human pancreas-specific protein/procarboxypeptidase B: A useful serum marker of acute pancreatitis
35. Clinical evaluation of a new rapid assay for serum lipase determination
36. Serum pancreas-specific protein in acute pancreatitis. Its clinical utility in comparison with serum amylase
37. Serum amylase and lipase in the evaluation of acute abdominal pain
38. Underestimation of acute pancreatitis: Patients with only a small increase in amylase/lipase levels can also have or develop severe acute pancreatitis
39. Diagnostic de la pancréatite aiguë par détection du trypsinogène II urinaire (Pancreatitis test)
40. Diagnostic de la pancréatite aiguë par détection du trypsinogène II urinaire (Pancreatitis test)
41. Urinary trypsinogen-2 test strip for acute pancreatitis
42. Urine trypsinogen-2 as marker of acute pancreatitis
43. Urinary trypsinogen-2 test strip in detecting ERCP-induced pancreatitis
44. Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis
45. Reliable screening for acute pancreatitis with rapid urine trypsinogen-2 test strip
46. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference
47. Evaluation of a new urinary amylase test strip in the diagnosis of acute pancreatitis
48. The renal clearance of amylase in renal insufficiency, acute pancreatitis, and macroamylasemia
49. Mechanism and specificity of increased amylase/creatinine clearance ratio in pancreatitis
50. The amylase creatinine clearance ratio in acute pancreatitis
51. The amylase-to-creatinine clearance ratio-a non-specific response to acute illness?
52. Postoperative elevation of amylase/creatinine clearance ratio in patients without pancreatitis
53. Sensitivity of the amylase-creatinine clearance ratio in acute pancreatitis
54. Specificity of increased amylase to creatinine clearance ratio in acute pancreatitis
55. Specificity of serum amylase and amylase creatinine clearance ratio in the diagnosis of acute and chronic pancreatitis
56. Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease
57. Immunoreactive trypsin in acute pancreatitis: Elevated levels do not correlate with hyperamylasaemia
58. Immunoreactive serum trypsin in diseases of the pancreas
59. Serum immunoreactive trypsin and trypsin inhibitors during acute pancreatitis
60. Serum phospholipase A2, immunoreactive trypsin, and trypsin inhibitors during human acute pancreatitis
61. Radioimmunoassay of cationic trypsin-like immunoreactivity in man
62. Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin
63. Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy
64. A method for determination of immunoreactive trypsin in complex with alpha 1-antitrypsin in human sera
65. Time-resolved immunofluorometric assay of trypsin-2 complexed with alpha 1-antitrypsin in serum
66. Serum complex of trypsin 2 and alpha 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis: Clinical study in consecutive patients
67. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis
68. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis
69. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: A multicentre study
70. Urinary trypsinogen activation peptides (TAP) are not increased in mild ERCP-induced pancreatitis
71. Serum pancreatic secretory trypsin inhibitor in pancreatic disease
72. The measurement of serum immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal cancer and pancreatic disease
73. Elimination of pancreatic secretory trypsin inhibitor from the circulation. A study in a man
74. Serum levels of immunoreactive PSTI in acute abdominal disorders, with special reference to a possible extrapancreatic PSTI production
75. Diagnostic and prognostic value of serum elastase 1 in acute pancreatitis
76. Serum immunoreactive elastase in diagnosis of pancreatic diseases. A sensitive marker for pancreatic cancer
77. Serum pancreatic enzyme behavior during the course of acute pancreatitis
78. A prospective study of serum pancreatic elastase-1 in the diagnosis and assessment of acute pancreatitis
79. Determination of elastase-1 serum levels in post ERCP/EST pancreatic damage
80. Carboxylic ester hydrolase. A sensitive serum marker and indicator of severity of acute pancreatitis
81. Immunoreactive phospholipase A2 in serum in acute pancreatitis and pancreatic cancer
82. Serum levels of pancreatitis-associated protein as indicators of the course of acute pancreatitis. Multicentric Study Group on Acute Pancreatitis
83. Pancreatitis associated protein as an early marker of acute pancreatitis
84. Clinical value of pancreatitis-associated protein in acute pancreatitis
85. Immunochemical characterization and quantitative distribution of pancreatic stone protein in sera and pancreatic secretions in pancreatic disorders
86. Serum pancreatic stone protein in pancreatic diseases
87. Measurement of serum PSP/reg-protein concentration in various diseases with a newly developed enzyme-linked immunosorbent assay
88. Molecular forms of serum pancreatic stone protein in acute pancreatitis
89. A novel serum assay for pancreatic cellular damage. II. High tissue specificity of a pancreatic protein
90. Isolation of a cDNA encoding a human serum marker for acute pancreatitis. Identification of pancreas-specific protein as pancreatic procarboxypeptidase B
91. A novel assay for pancreatic cellular damage: IV. Serum concentrations of pancreas-specific protein (PASP) in acute pancreatitis and other abdominal diseases
92. Human pancreas-specific protein/procarboxypeptidase B: A useful serum marker of acute pancreatitis
93. Isoforms of procarboxypeptidase B, (pancreas-specific protein, PASP) in human serum, pancreatic tissue and juice
94. « Human pancreas-specific protein » (procarboxypeptidase B): A valuable marker in pancreatitis?
95. Combined serum amylase and lipase determinations for diagnosis of suspected acute pancreatitis
96. Is the association of serum lipase with β2 microglobuline or C-reactive protein useful for establishing the diagnosis and prognosis of patients with acute pancreatitis?
97. Simultaneous serum assay of lipase and interleukin-6 for early diagnosis and prognosis of acute pancreatitis
98. Early diagnosis and classification in acute pancreatitis. A comparison of clinical outcome with findings at computed tomography and Ranson's prognostic signs
99. Diagnosis of necrotizing pancreatitis. Comparison between contrast medium-computed tomography and ultrasonics in a clinical study
100. Comparison of the usefulness of ultrasonography and computed tomography in diagnosis of acute necrotizing pancreatitis
101. Incorrect estimation of severity of acute pancreatitis by contrast-enhanced computed tomography
102. Accuracy of CT in estimating extent of pancreatic necrosis
103. Pancreatic fluid collections prior to intervention: Evaluation with MR imaging compared with CT and US
104. T2-weighted and dynamic enhanced MRI in acute pancreatitis: Comparison with contrast enhanced CT
105. Ultrasonography, computed tomography and percutaneous intervention in acute pancreatitis: A serial study
106. Comparison of MR and CT scanning in severe acute pancreatitis: Initial experiences
107. CT of acute pancreatitis: Correlation between lack of contrast enhancement and pancreatic necrosis
108. Dynamic contrast enhanced computed tomography: A precise technique for identifying and localising pancreatic necrosis
109. Identification of pancreas necrosis in severe acute pancreatitis: Imaging procedures versus clinical staging
110. Early detection of acute fulminant pancreatitis by contrast-enhanced computed tomography
111. Results of computed tomographic diagnosis in the grading of acute pancreatitis
112. Valeur pronostique de la tomodensitométrie dans la pancréatite aiguë: Contribution de l'injection de produit de contraste intraveineux
113. Value of contrast-enhanced computerized tomography in the early diagnosis and prognosis of acute pancreatitis. A prospective study of 202 patients
114. Acute pancreatitis. The classification of its severity by dynamic pancreatography and the results of surgical treatment
115. Diagnostic imaging of acute pancreatitis: Prospective study using CT and sonography
116. Is an early ultrasound scan of value in acute pancreatitis?
117. Acute pancreatitis and its complications. Computed tomography and sonography
118. Ultrasonic examination of the pancreas
119. Collections of fluid after pancreatitis: Evaluation by computed tomography and ultrasonography
120. Computed tomography and acute pancreatitis
121. Acute pancreatitis: Clinical vs. CT findings
122. Acute pancreatitis: Value of CT in establishing prognosis
123. Incremental dynamic bolus computed tomography of acute pancreatitis
124. Prediction of pancreatic necrosis by dynamic pancreatography
125. A new method for the diagnosis of acute hemorrhagic-necrotizing pancreatitis using contrast-enhanced CT
126. Contrast-enhanced computed tomography and microangiography of the pancreas in acute human hemorrhagic/necrotizing pancreatitis
127. Computerized tomography in acute and chronic pancreatitis
128. Evaluation of necrotizing pancreatitis in the opossum by dynamic contrast-enhanced computed tomography: Correlation between radiographic and morphologic changes
129. Rapid-bolus contrast-enhanced dynamic computed tomography in acute pancreatitis: A prospective study
130. Intravenous contrast medium accentuates the severity of acute necrotizing pancreatitis in the rat
131. Intravenous contrast medium impairs oxygenation of the pancreas in acute necrotizing pancreatitis in the rat
132. Intravenous contrast medium does not increase the severity of acute necrotizing pancreatitis in the opossum
133. A retrospective analysis of the effect of contrast-enhanced CT on the outcome of acute pancreatitis
134. Contrast-enhanced dynamic computed tomography does not aggravate the clinical severity of patients with severe acute pancreatitis: Reevaluation of the effect of intravenous contrast medium on the severity of acute pancreatitis
135. Fast MR imaging techniques: Impact in the abdomen
136. Retroperitoneal collections-aetiology and radiological implications
137. Contrast-enhanced magnetic resonance imaging for the detection of acute haemorrhagic necrotizing pancreatitis
138. Pancreatic disease: Prospective comparison of CT, ERCP, and 1.5-T MR imaging with dynamic gadolinium enhancement and fat suppression
139. Acute pancreatitis: Interobserver agreement and correlation of CT and MR cholangiopancreatography with outcome
140. MR imaging of the pancreas
141. Pancreatic masses with inconclusive findings on spiral CT: Is there a role for MRI?
142. Chronic pancreatitis: MR imaging features before and after administration of gadopentetate dimeglumine
143. Pancreatic signal intensity on T1-weighted fat saturation MR images: Clinical correlation
144. The relative safety of MRI contrast agent in acute necrotizing pancreatitis
145. Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis
146. The role of surgery in the management of acute pancreatitis
147. Gallstone pancreatitis: The timing of surgery
148. Acute pancreatitis: A lethal disease of increasing incidence
149. Biliary sludge as a cause of acute pancreatitis
150. Idiopathic recurrent pancreatitis. An approach to diagnosis and treatment
151. Physical characteristics of gallstones and the calibre of the cystic duct in patients with acute pancreatitis
152. Gallstone pancreatitis. Local predisposing factors
153. The biliary tract in patients with acute gallstone pancreatitis
154. Sex differences in gallstone pancreatitis
155. Gallstone size and risk of pancreatitis
156. The early identification of patients with gallstone associated pancreatitis using clinical and biochemical factors only
157. Rapid resolution of high level hyperamylasemia as a guide to clinical diagnosis and timing of surgical treatment in patients with gallstones
158. Biochemical prediction of gallstones in acute pancreatitis: A prospective study of three systems
159. Predictability of clinicobiochemical scoring systems for early identification of severe gallstone-associated pancreatitis
160. Clinicobiochemical factors in predicting gallstones in necrotizing pancreatitis
161. The role of clinical and biochemical criteria and endoscopic retrograde cholangiopancreatography in the urgent diagnosis of common bile duct stones in acute pancreatitis
162. Gallstone pancreatitis and the effect of cholecystectomy: A population-based cohort study
163. Diagnostic considerations in acute alcoholic and gallstone pancreatitis
164. Prediction of gallstone pancreatitis by computer
165. Early detection of biliary pancreatitis
166. Lipase/amylase ratio. A new index that distinguishes acute episodes of alcoholic from nonalcoholic acute pancreatitis
167. Evaluation of pancreatic amylase immunoassay in acute pancreatitis
168. Detection of gallstones after acute pancreatitis
169. Biochemical identification of patients with gallstones associated with acute pancreatitis on the day of admission to hospital
170. Lipase/amylase ratio: Not helpful in the early etiological differentiation of acute pancreatitis
171. Gallstones and acute hepatitis
172. Occult microlithiasis in 'idiopathic' acute pancreatitis: Prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy
173. The urgent diagnosis of gallstones in acute pancreatitis: A prospective study of three methods
174. Biochemical prediction of gallstones early in an attack of acute pancreatitis
175. Gallstone pancreatitis: A prospective study on the incidence of cholangitis and clinical predictors of retained common bile duct stones
176. Predicting gallstone pancreatitis with laboratory parameters: A meta-analysis
177. A scoring system for early differentiation of the etiology of acute pancreatitis
178. Enzymatic markers of gallstone-induced pancreatitis identified by ROC curve analysis, discriminant analysis, logistic regression, likelihood ratios, and information theory
179. The lipase to amylase ratio in acute pancreatitis
180. Blood tests for detection of alcoholic cause of acute pancreatitis
181. Clinical significance of ultrasonography, computed tomography, and biochemical tests in the rapid diagnosis of gallstone-related pancreatitis: A prospective study
182. Detection of biliary origin of acute pancreatitis. Comparison of laboratory tests, ultrasound, computed tomography, and ERCP
183. Value of endoscopic retrograde cholangiopancreatography in determining the cause but not course of acute pancreatitis
184. Diagnosis of acute pancreatitis: Value of endoscopic sonography
185. Acute biliary pancreatitis: Diagnosis and management
186. Acute biliary pancreatitis: The roles of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography
187. Ultrasonographic evaluation of the common bile duct in biliary acute pancreatitis patients: Comparison with endoscopic retrograde cholangiopancreatography
188. Prospective assessment of the utility of EUS in the evaluation of gallstone pancreatitis
189. A prospective study of the clinical value and accuracy of grey scale ultrasound in detecting gallstones
190. Exploration of the biliary system in recurrent acute pancreatitis of undetermined etiology despite normal cholecystography
191. Oral cholecystography in the early phase of acute alcoholic pancreatitis. A prospective, randomized comparison of Telepaque and Bilopaque
192. Diagnostic imaging procedures in acute pancreatitis. Comparison of ultrasound, intravenous cholangiography, and oral cholecystography
193. The timing of cholecystectomy in patients with gallstone pancreatitis. A retrospective analysis of 89 patients
194. The usefulness of stool screening for diagnosing cholelithiasis in acute pancreatitis. A description of the technique
195. Tyropanoate cholecystography early in the course of acute pancreatitis
196. The role of intravenous cholangiography in pre-operative assessment for laparoscopic cholecystectomy
197. Is intravenous cholangiography still useful?
198. Detection of gallstones after acute pancreatitis
199. Choledocholithiasis: Evaluation with MR cholangiography
200. Choledocholithiasis: Comparison of MR cholangiography and endoscopic retrograde cholangiography
201. Current status of MR cholangiopancreatography
202. Choledocholithiasis and bile duct stenosis: Diagnostic accuracy of MR cholangiopancreatography
203. Diagnosis of choledocholithiasis: EUS or magnetic resonance cholangiography? A prospective controlled study
204. Evaluation of magnetic resonance cholangiography in the management of bile duct stones
205. Prospective evaluation of magnetic resonance cholangiography to detect common bile duct stones before laparoscopic cholecystectomy
206. Half-Fourier RARE MR cholangiopancreatography: Experience in 300 subjects
207. The efficacy of magnetic resonance cholangiography for the evaluation of patients with suspected choledocholithiasis before laparoscopic cholecystectomy
208. Magnetic resonance-cholangiopancreatography in the diagnosis of biliopancreatic diseases
209. MR cholangiopancreatography: Prospective comparison of a breath-hold 2D projection technique with diagnostic ERCP
210. Value of MR cholangiography in the diagnosis of obstructive diseases of the biliary tree: A study of 58 cases
211. Choledocholithiasis: Evaluation of MR cholangiography for diagnosis
212. MR cholangiopancreaticography and endoscopic retrograde cholangiopancreaticography in patients with suspected common bile duct stones
213. A prospective comparison of magnetic resonance cholangiopancreatography with endoscopic retrograde cholangiopancreatography in the evaluation of patients with suspected biliary tract disease
214. Use of magnetic resonance cholangiography in the diagnosis of choledocholithiasis: Prospective comparison with a reference imaging method
215. Detection of choledocholithiasis with MR cholangiography: Comparison of three-dimensional fast spin-echo and single- and multisection half-Fourier rapid acquisition with relaxation enhancement sequences
216. Choledocolithiasis: Diagnostic accuracy of MR cholangiopancreatography. Three-year experience
217. MRCP: The new standard for radiologic evaluation of cholelithiasis and choledocholithiasis?
218. Utility of magnetic resonance cholangiography in the evaluation of patients with gallstone pancreatitis
219. Performance, patient acceptance, appropriateness of indications and potential influence on outcome of EUS: A prospective study in 397 consecutive patients
220. Complications of endoscopic biliary sphincterotomy
221. Lithiase de la vole biliaire principale: Échoendoscopie. Résultats et indications
222. EUS for detection of occult cholelithiasis in patients with idiopathic pancreatitis
223. Sphinctérotomie endoscopique et lithiase de la vole biliaire principale. Réalité et perspectives
224. Relative merits of ultrasonography, computed tomography and cholangiography in patients of surgical obstructive jaundice
225. Ultrasonography, CT, and ERCP in the diagnosis of choledochal stones
226. Endoscopic ultrasonography versus cholangiography for the diagnosis of choledocholithiasis
227. Prospective comparison of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in the detection of bile duct stones
228. Prospective controlled study of endoscopic ultrasonography and endoscopic retrograde cholangiography in patients with suspected common-bile duct lithiasis
229. Stimulation of gallbladder by intravenous infusion of amino acid: A new method to obtain duodenal bile for bile analyses
230. Acute pancreatitis and microcrystals. Importance of the bile collection and biochemical parameters
231. Bilirubinate granules: Main pathologic bile component in patients with idiopathic acute pancreatitis
232. Role of duodenal bile crystal analysis in the investigation of 'idiopathic' pancreatitis
233. Drug-induced acute pancreatitis: Further criticism
234. Drug-induced pancreatitis: A critical review
235. Review article: Drug-induced pancreatitis
236. Drug-induced acute pancreatitis: Incidence and severity
237. Pancréatites iatrogènes médicamenteuses
238. Drug-induced pancreatitis
239. Drug-induced pancreatitis
240. Drug-induced acute pancreatitis
241. Drug-induced acute pancreatitis. A critical review
242. Acute drug and toxin induced pancreatitis
243. Drug-associated acte pancreatitis: Twenty-one years of spontaneous reporting in the Netherlands
244. Pancréatoxicité médicamenteuse. Description d'un fichier microinformatisé des médicaments responsables
245. The etiological factors in 73 cases of acute pancreatitis
246. Drug-induced pancreatitis
247. Drug-associated pancreatitis: Facts and fiction
248. Pancréatites aiguës médicamenteuses
249. Définition et critères d'imputabilité des atteintes pancréatiques aiguës médicamenteuses
250. Infectious causes of acute pancreatitis
251. Clinical presentation of mucin-secreting tumors of the pancreas
252. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: Differences in clinical characteristics and surgical management
253. Intraductal papillary-mucinous tumors of the pancreas: Clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic
254. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation
255. Mutations in the gene encoding the serine protease inhibitor. Kazal type 1 are associated with chronic pancreatitis
256. Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis
257. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis
258. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
259. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis
260. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
261. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response
262. Eosinophilic pancreatitis mimicking pancreatic neoplasia: EUS and ERCP findings - Is nonsurgical diagnosis possible?
263. Eosinophilic gastroenteritis presenting with acute pancreatitis
264. Non-alcoholic duct destructive chronic pancreatitis
265. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy
266. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogren's syndrome
267. Eosinophilic pancreatitis: Report of a case